CSIMarket
 


Longeveron Inc   (LGVN)
Other Ticker:  
 


Longeveron Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



LGVN Gross Profit Margin (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Revenue Change -4.7 % - - - -
Seq. Revenue Change 25.95 % - - -52.56 % -
Revenue In Millions $0.47 $0.37 $-0.72 $0.23 $0.49
Gross Profit Margin 34.33 % 81.08 % - 70.69 % 42.54 %
Gross Profit Margin Total Ranking # # 3243 # 1327 # # 1725
Gross Profit In Millions $0.16 $0.30 $-0.37 $0.16 $0.21
Y / Y Gross Profit Change -23.08 % - - - -
Seq. Gross Profit Change -46.67 % - - -21.15 % -


Commenting Second Quarter 2022 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 34.33 % due to increase in Cost of Sales and despite Revenue increase of 25.95 % to $0 millions.
Longeveron Inc achieved highest Gross Profit Margin in II. Quarter

Observing second quarter 2022 results within Major Pharmaceutical Preparations industry Longeveron Inc has achieved highest Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to , from total ranking in previous quarter at 3243.
Learn about Gross Margin
LGVN's Gross Profit Margin second quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
81.08 % 57.16 % 34.33 %
(Mar 31 2022)   (Jun 30 2022)




Other Gross Profit Margin Profitability Ratios
LGVN's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
LGVN's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for LGVN's Competitors
Gross Profit Margin Profit Margin for Longeveron Inc 's Suppliers
Gross Profit Margin Profit Margin for LGVN's Customers

You may also want to know
LGVN's Annual Growth Rates LGVN's Profitability Ratios LGVN's Asset Turnover Ratio LGVN's Dividend Growth
LGVN's Roe LGVN's Valuation Ratios LGVN's Financial Strength Ratios LGVN's Gross Profit Growth
LGVN's Roa LGVN's Inventory Turnover Ratio LGVN's Growth Rates LGVN's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2022, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2022 MRQ Gross ProfitJun 30 2022 MRQ Revenue
Aurinia Pharmaceuticals Inc   94.33 %$ 26.592 $ 28.191 
United Therapeutics Corporation  93.64 %$ 437.200 $ 466.900 
Cti Biopharma Corp   92.56 %$ 11.412 $ 12.329 
Agios Pharmaceuticals Inc   92.21 %$ 5.147 $ 5.582 
Ultragenyx Pharmaceutical Inc   90.74 %$ 81.073 $ 89.343 
Vanda Pharmaceuticals Inc   90.59 %$ 58.331 $ 64.390 
Ocular Therapeutix Inc   90.58 %$ 11.111 $ 12.266 
Albireo Pharma inc   90.54 %$ 7.430 $ 8.206 
Radius Health inc.  90.43 %$ 52.709 $ 58.285 
Wellness Center Usa Inc  90.33 %$ 0.097 $ 0.108 
Aadi Bioscience Inc   90.08 %$ 3.096 $ 3.437 
Amicus Therapeutics inc   89.85 %$ 72.534 $ 80.731 
Optinose Inc   89.59 %$ 18.439 $ 20.582 
Y mabs Therapeutics inc   89.44 %$ 9.657 $ 10.797 
Urogen Pharma Ltd   88.88 %$ 14.758 $ 16.604 
Axsome Therapeutics Inc   88.86 %$ 7.837 $ 8.820 
Celularity Inc   88.74 %$ 3.351 $ 3.776 
Vertex Pharmaceuticals Inc  88.08 %$ 1,934.400 $ 2,196.200 
Supernus Pharmaceuticals inc   87.97 %$ 149.594 $ 170.051 
Aveo Pharmaceuticals Inc   87.89 %$ 22.239 $ 25.304 
Assertio Holdings inc   87.11 %$ 30.603 $ 35.131 
Sage Therapeutics Inc   86.68 %$ 1.301 $ 1.501 
Cure Pharmaceutical Holding Corp   86.64 %$ 0.973 $ 1.123 
Xbiotech Inc   86.47 %$ 1.323 $ 1.530 
Catalyst Pharmaceuticals Inc   85.61 %$ 45.470 $ 53.113 
Akebia Therapeutics Inc   85.33 %$ 108.159 $ 126.759 
Alimera Sciences Inc   85.17 %$ 12.438 $ 14.604 
Alnylam Pharmaceuticals Inc   84.86 %$ 190.780 $ 224.818 
Maravai Lifesciences Holdings Inc   84.55 %$ 205.236 $ 242.732 
Jaguar Health inc   84.39 %$ 2.465 $ 2.921 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SVFA's Profile

Stock Price

SVFA's Financials

Business Description

Fundamentals

Charts & Quotes

SVFA's News

Suppliers

SVFA's Competitors

Customers & Markets

Economic Indicators

SVFA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071